SCHEMBL2871464

SCHEMBL2871464

CCCOc1nc2ccccc2c(-n2nccn2)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.40
▸ MAPT P10636 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SQOR Q9Y6N5 2/20 0.38
▸ TP53 P04637 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ MAPK8 P45983 2/20 0.36
▸ PRKD3 O94806 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ MAP4K2 Q12851 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906146 0.90 SQOR (0.47) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL7916445 0.87 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL7916403 0.85 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL7914410 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL7914421 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL20975374 0.80 PDE10A (0.44) ALDH1A1MAPK1HSD17B10KDM4ECYP1A2
SCHEMBL7913465 0.80 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL2871462 0.79 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10KDM4EMAPT
SCHEMBL12495119 0.75 HTR2C (0.41) ALDH1A1MAPK1HSD17B10MAPTCYP1A2
SCHEMBL7913446 0.72 SQOR (0.44) ALDH1A1KDM4EMAPTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2253620-B1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS WYETH HOLDINGS LLC (US) 2014-03-12 — — EP disclosed
EP-2253620-A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors Wyeth Holdings Corporation (US) 2010-11-24 — — EP disclosed
US-6297258-B1 USEFUL AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE. AMERICAN CYANAMID COMPANY 2001-10-02 — — US disclosed
Send feedback